Boston Scientific Corp.
NYSE:BSX 4:00:00 PM EDT
| Market Cap (Intraday) | 74.06B |
| Current PE | 82.11 |
| Forward PE | 25.98 |
| 2yr Forward PE | 22.82 |
| 10-Day MA | $51.55 |
| 50-Day MA | $51.65 |
| 200-Day MA | $46.04 |
Boston Scientific Corp. Stock, NYSE:BSX
300 Boston Scientific Way, Marlborough, Massachusetts 01752-1234
United States of America
Phone: +1.508.683.4000
Number of Employees: 45000
Description
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.